InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Febbo William J, Chief Executive Officer. Insider active across 6 companies, notably OptimizeRx Corp. Aggregated, 35 reports have been published. Breakdown: 3 buys · 7 sells. Total volume traded: €5.9m. Activity tracked since 16 August 2021. The latest transaction was disclosed on 14 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Febbo William J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
78,704 sharesCommon StockSEC:0001193125-26-285686:0
45,000 shares0Common StockSEC:0001193125-26-159101:0
401 shares@ US$6.640.0% of flowCommon StockSEC:0001628280-25-006692:0
20,000 shares@ US$5.0110.9% of flowCommon StockSEC:0001628280-24-051352:0
Canonical exit: 12 Mar 2025 (T+90)
162,583 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085379:0
21,598 sharesCommon StockSEC:0001213900-24-061515:0
28,895 shares0Common StockSEC:0001628280-24-027755:0
15,000 shares0Common StockSEC:0001628280-24-017552:0
60,000 shares0Common StockSEC:0001628280-24-016621:0
9,628 shares0Common StockSEC:0001628280-24-001718:0
2,500 sharesCommon StockSEC:0001213900-23-054872:0
75,000 shares0Common StockSEC:0001362118-23-000046:0
52,632 sharesCommon StockSEC:0001213900-23-049755:0
2,500 sharesCommon StockSEC:0001213900-23-026436:0
9,628 sharesCommon StockSEC:0001628280-23-001817:0
2,500 sharesCommon StockSEC:0001019056-23-000002:0
2,500 sharesCommon StockSEC:0001019056-22-000607:0
5,400 shares@ US$16.17850.8% of flowCommon StockSEC:0001213900-22-050555:0
Canonical exit: 17 Nov 2022 (T+90)
2,500 sharesCommon StockSEC:0001019056-22-000538:0
30,000 shares@ US$1.99100.0% of flowCommon StockSEC:0001213900-22-030199:0
Canonical exit: 25 Aug 2022 (T+90)
5,981 sharesCommon StockSEC:0001019056-22-000310:0
20,000 shares@ US$4.02100.0% of flowCommon StockSEC:0001019056-22-000256:0
9,200 shares@ US$43.3796.0% of flowCommon StockSEC:0001213900-22-008987:0
45,586 sharesCommon StockSEC:0001019056-22-000226:0
8,140 shares@ US$46.9155.7% of flowCommon StockSEC:0001213900-22-002854:0
25 of 35 declarations
About Febbo William J
FEBBO WILLIAM J is President and Chief Executive Officer. The record shows 35 filings, all in the available sample, with buys of EUR 237594 and sells of EUR 6028852 over the period from 2021-07-02 to 2026-06-26. The main filings concern OptimizeRx Corp, with sales published on 2021-10-19 for EUR 1210607.185080527, on 2021-11-17 for EUR 1197040.740310487, on 2021-09-17 for EUR 926923.2182573355, on 2021-08-17 for EUR 855374.0793883505, on 2021-12-17 for EUR 807307.6748337478, and on 2022-02-23 for EUR 351108.5780589673. The modal transaction nature is Attribution.
